To Investigate the Safety and Efficacy of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular Hypertension

Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

NCT01868126 ·Status: COMPLETED ·Phase: PHASE2

A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study

NCT03216902 ·Status: COMPLETED ·Phase: PHASE2

DE-111 Against Timolol Ophthalmic Solution 0.5%

NCT01342094 ·Status: COMPLETED ·Phase: PHASE3

Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma

NCT00443924 ·Status: COMPLETED ·Phase: PHASE1

A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in China

NCT06666855 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Multi-center Phase II Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

NCT02179008 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT01279083 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma

NCT03960866 ·Status: COMPLETED ·Phase: PHASE2

A Comparative Confirmatory Study of STN1012600 in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

NCT05495061 ·Status: COMPLETED ·Phase: PHASE3

A Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHT

NCT01654484 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

NCT04742283 ·Status: COMPLETED ·Phase: PHASE2

Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily

NCT03067415 ·Status: UNKNOWN ·Phase: PHASE2

28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension

NCT02531152 ·Status: COMPLETED ·Phase: PHASE1

Open-Label Study of Safety of H1337 in Healthy Volunteers

NCT06572397 ·Status: COMPLETED ·Phase: PHASE1

Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost

NCT00637130 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

NCT02105272 ·Status: COMPLETED ·Phase: PHASE3

Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy

NCT01426464 ·Status: UNKNOWN ·Phase: PHASE2

A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-

NCT02623738 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7058584 Following 7 Days of Instillation of Eye Drops in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

NCT03293992 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Effect of IOP-lowering With TO-O-1001 Eye Drops in Healthy Subjects and in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT05456724 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle Glaucoma

NCT03131167 ·Status: COMPLETED ·Phase: PHASE1

Phase 2 Dose-Response Study Evaluating the Safety and Efficacy of NCX 470 vs Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension

NCT03657797 ·Status: COMPLETED ·Phase: PHASE2

Safety/Efficacy Study: OPA-6566 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension

NCT01410188 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Phase III Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution Compared With Latanoprost Ophthalmic Solution in Subjects With OAG or OHT

NCT02981446 ·Status: COMPLETED ·Phase: PHASE3

DE-117 Spectrum 5 Study

NCT03697811 ·Status: COMPLETED ·Phase: PHASE3